New Horizon Health Finds Formula For Profits Ahead Of Schedule - Burning Rock Biotech (NASDAQ:BNR)

Key Takeaways: New Horizon Health posted a 61.3 million yuan adjusted profit in the first half of 2023, benefiting from soaring revenue for its three approved products The company sees big growth potential for its home-based cervical cancer screening product By Molly Wen

Related Keywords

Hong Kong ,China ,Chen Yiyou ,Molly Wen ,Zhu Yeqing ,Horizon Health Ltd ,Horizon Health ,China National Drug Administration ,Key Takeaways ,New Horizon Health ,New Horizon ,Pupu Tube ,Chief Scientific Officer Chen Yiyou ,National Drug Administration ,Burning Rock ,